Medtronic (MDT) Non-Current Deferred Tax Liability (2014 - 2026)

Medtronic's Non-Current Deferred Tax Liability history runs 13 years deep, the most recent figure standing at $365.0 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability fell 19.25% year-over-year to $365.0 million; the TTM figure through Jan 2026 stood at $365.0 million (down 19.25% YoY), while the FY2025 annual figure was $403.0 million, down 21.75% from the prior year.
• Non-Current Deferred Tax Liability came in at $365.0 million for Q1 2026 at Medtronic, down from $386.0 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $2.1 billion in Q2 2023 to a low of $365.0 million in Q1 2026.
• A 5-year average of $765.8 million and a median of $615.0 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability climbed 5.76% in 2023 and tumbled 75.19% in 2024, its largest moves.
• Medtronic's Non-Current Deferred Tax Liability stood at $871.0 million in 2022, then slipped by 21.24% to $686.0 million in 2023, then tumbled by 31.05% to $473.0 million in 2024, then decreased by 18.39% to $386.0 million in 2025, then declined by 5.44% to $365.0 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $365.0 million, $386.0 million, and $416.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison